106 related articles for article (PubMed ID: 25070263)
1. High glucose reduces hepatic glycogenesis by suppression of microRNA‑152.
Zhao X; Lu Y; Wang F; Dou L; Wang L; Guo J; Li J
Mol Med Rep; 2014 Oct; 10(4):2073-8. PubMed ID: 25070263
[TBL] [Abstract][Full Text] [Related]
2. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes.
Liu TY; Shi CX; Gao R; Sun HJ; Xiong XQ; Ding L; Chen Q; Li YH; Wang JJ; Kang YM; Zhu GQ
Clin Sci (Lond); 2015 Nov; 129(10):839-50. PubMed ID: 26201094
[TBL] [Abstract][Full Text] [Related]
3. MiR-301a mediates the effect of IL-6 on the AKT/GSK pathway and hepatic glycogenesis by regulating PTEN expression.
Dou L; Wang S; Sui X; Meng X; Shen T; Huang X; Guo J; Fang W; Man Y; Xi J; Li J
Cell Physiol Biochem; 2015; 35(4):1413-24. PubMed ID: 25790935
[TBL] [Abstract][Full Text] [Related]
4. MiR-19a regulates PTEN expression to mediate glycogen synthesis in hepatocytes.
Dou L; Meng X; Sui X; Wang S; Shen T; Huang X; Guo J; Fang W; Man Y; Xi J; Li J
Sci Rep; 2015 Jun; 5():11602. PubMed ID: 26111969
[TBL] [Abstract][Full Text] [Related]
5. Protein kinase Cδ but not PKCα is involved in insulin-induced glucose metabolism in hepatocytes.
Brutman-Barazani T; Horovitz-Fried M; Aga-Mizrachi S; Brand C; Brodie C; Rosa J; Sampson SR
J Cell Biochem; 2012 Jun; 113(6):2064-76. PubMed ID: 22271577
[TBL] [Abstract][Full Text] [Related]
6. Epigallocatechin-3-gallate ameliorates insulin resistance in hepatocytes.
Ma SB; Zhang R; Miao S; Gao B; Lu Y; Hui S; Li L; Shi XP; Wen AD
Mol Med Rep; 2017 Jun; 15(6):3803-3809. PubMed ID: 28393248
[TBL] [Abstract][Full Text] [Related]
7. Bile acids enhance the activity of the insulin receptor and glycogen synthase in primary rodent hepatocytes.
Han SI; Studer E; Gupta S; Fang Y; Qiao L; Li W; Grant S; Hylemon PB; Dent P
Hepatology; 2004 Feb; 39(2):456-63. PubMed ID: 14767998
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-20a-5p contributes to hepatic glycogen synthesis through targeting p63 to regulate p53 and PTEN expression.
Fang W; Guo J; Cao Y; Wang S; Pang C; Li M; Dou L; Man Y; Huang X; Shen T; Li J
J Cell Mol Med; 2016 Aug; 20(8):1467-80. PubMed ID: 27019188
[TBL] [Abstract][Full Text] [Related]
9. The role of protein kinase B/Akt in insulin-induced inactivation of phosphorylase in rat hepatocytes.
Aiston S; Hampson LJ; Arden C; Iynedjian PB; Agius L
Diabetologia; 2006 Jan; 49(1):174-82. PubMed ID: 16341839
[TBL] [Abstract][Full Text] [Related]
10. Glycogen synthase kinase 3alpha-specific regulation of murine hepatic glycogen metabolism.
MacAulay K; Doble BW; Patel S; Hansotia T; Sinclair EM; Drucker DJ; Nagy A; Woodgett JR
Cell Metab; 2007 Oct; 6(4):329-37. PubMed ID: 17908561
[TBL] [Abstract][Full Text] [Related]
11. Exposures to arsenite and methylarsonite produce insulin resistance and impair insulin-dependent glycogen metabolism in hepatocytes.
Zhang C; Fennel EMJ; Douillet C; Stýblo M
Arch Toxicol; 2017 Dec; 91(12):3811-3821. PubMed ID: 28952001
[TBL] [Abstract][Full Text] [Related]
12. Hepatic miR-181b-5p Contributes to Glycogen Synthesis Through Targeting EGR1.
Wang S; Liang C; Ai H; Yang M; Yi J; Liu L; Song Z; Bao Y; Li Y; Sun L; Zhao H
Dig Dis Sci; 2019 Jun; 64(6):1548-1559. PubMed ID: 30627917
[TBL] [Abstract][Full Text] [Related]
13. Mir-338-3p Mediates Tnf-A-Induced Hepatic Insulin Resistance by Targeting PP4r1 to Regulate PP4 Expression.
Dou L; Wang S; Sun L; Huang X; Zhang Y; Shen T; Guo J; Man Y; Tang W; Li J
Cell Physiol Biochem; 2017; 41(6):2419-2431. PubMed ID: 28467989
[TBL] [Abstract][Full Text] [Related]
14. [Sar1, Ile4, Ile8]-angiotensin II Potentiates Insulin Receptor Signalling and Glycogen Synthesis in Hepatocytes.
Sanni SJ; Lyngsø C; Gammeltoft S; Hansen JL
Basic Clin Pharmacol Toxicol; 2018 May; 122(5):460-469. PubMed ID: 29136335
[TBL] [Abstract][Full Text] [Related]
15. A role for Akt in epidermal growth factor-stimulated cell cycle progression in cultured hepatocytes: generation of a hyperproliferative window after adenoviral expression of constitutively active Akt.
Luo Y; Dixon CJ; Hall JF; White PJ; Boarder MR
J Pharmacol Exp Ther; 2007 Jun; 321(3):884-91. PubMed ID: 17371807
[TBL] [Abstract][Full Text] [Related]
16. Hydrogen sulfide impairs glucose utilization and increases gluconeogenesis in hepatocytes.
Zhang L; Yang G; Untereiner A; Ju Y; Wu L; Wang R
Endocrinology; 2013 Jan; 154(1):114-26. PubMed ID: 23183179
[TBL] [Abstract][Full Text] [Related]
17. Modified Si-Miao-San extract inhibits inflammatory response and modulates insulin sensitivity in hepatocytes through an IKKβ/IRS-1/Akt-dependent pathway.
Liu K; Luo T; Zhang Z; Wang T; Kou J; Liu B; Huang F
J Ethnopharmacol; 2011 Jul; 136(3):473-9. PubMed ID: 21296137
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA 152 regulates hepatic glycogenesis by targeting PTEN.
Wang S; Wang L; Dou L; Guo J; Fang W; Li M; Meng X; Man Y; Shen T; Huang X; Li J
FEBS J; 2016 May; 283(10):1935-46. PubMed ID: 26996529
[TBL] [Abstract][Full Text] [Related]
19. Role of Akt2 in contraction-stimulated cell signaling and glucose uptake in skeletal muscle.
Sakamoto K; Arnolds DE; Fujii N; Kramer HF; Hirshman MF; Goodyear LJ
Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E1031-7. PubMed ID: 16803855
[TBL] [Abstract][Full Text] [Related]
20. Long-term treatment with novel glycogen synthase kinase-3 inhibitor improves glucose homeostasis in ob/ob mice: molecular characterization in liver and muscle.
Kaidanovich-Beilin O; Eldar-Finkelman H
J Pharmacol Exp Ther; 2006 Jan; 316(1):17-24. PubMed ID: 16169938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
